Stanic K - Search Results

1

Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.

Stanic K, Turnsek N, Vrankar M. Stanic K, et al. Radiol Oncol. 2019 Nov 20;53(4):453-458. doi: 10.2478/raon-2019-0053. Radiol Oncol. 2019. PMID: 31747381 Free PMC article.

2

Prophylactic cranial irradiation in patients with small-cell lung cancer: the experience at the Institute of Oncology Ljubljana.

Stanic K, Kovac V. Stanic K, et al. Radiol Oncol. 2010 Sep;44(3):180-6. doi: 10.2478/v10019-010-0038-4. Epub 2010 Sep 9. Radiol Oncol. 2010. PMID: 22933913 Free PMC article.

3

Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.

Stanic K, Zwitter M, Hitij NT, Kern I, Sadikov A, Cufer T. Stanic K, et al. Radiol Oncol. 2014 Apr 25;48(2):173-83. doi: 10.2478/raon-2014-0016. eCollection 2014 Jun. Radiol Oncol. 2014. PMID: 24991207 Free PMC article.

4

Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations.

Zwitter M, Stanic K, Rajer M, Kern I, Vrankar M, Edelbaher N, Kovac V. Zwitter M, et al. Among authors: stanic k. Radiol Oncol. 2014 Nov 5;48(4):361-8. doi: 10.2478/raon-2014-0038. eCollection 2014 Dec. Radiol Oncol. 2014. PMID: 25435849 Free PMC article.

5

Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.

Zwitter M, Rajer M, Stanic K, Vrankar M, Doma A, Cuderman A, Grmek M, Kern I, Kovac V. Zwitter M, et al. Among authors: stanic k. Cancer Biol Ther. 2016 Aug 2;17(8):833-9. doi: 10.1080/15384047.2016.1195049. Epub 2016 Jun 3. Cancer Biol Ther. 2016. PMID: 27261103 Free PMC article. Clinical Trial.

6

Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer.

Hitij NT, Kern I, Sadikov A, Knez L, Stanič K, Zwitter M, Cufer T. Hitij NT, et al. Among authors: stanic k. Clin Lung Cancer. 2017 May;18(3):e187-e196. doi: 10.1016/j.cllc.2016.11.021. Epub 2016 Dec 2. Clin Lung Cancer. 2017. PMID: 28089159

7

PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy.

Vrankar M, Zwitter M, Kern I, Stanic K. Vrankar M, et al. Among authors: stanic k. Neoplasma. 2018;65(1):140-146. doi: 10.4149/neo_2018_170206N77. Neoplasma. 2018. PMID: 29322798

8

1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups.

Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Rudat V, Schild SE. Rades D, et al. Among authors: stanic k. Radiat Oncol. 2018 Feb 8;13(1):21. doi: 10.1186/s13014-018-0968-3. Radiat Oncol. 2018. PMID: 29422106 Free PMC article.

9

Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy.

Vrankar M, Stanic K. Vrankar M, et al. Among authors: stanic k. Radiol Oncol. 2018 Feb 21;52(3):281-288. doi: 10.2478/raon-2018-0009. Radiol Oncol. 2018. PMID: 30210037 Free PMC article.

10

Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?

Marinko T, Stanic K. Marinko T, et al. Among authors: stanic k. Radiol Oncol. 2018 Mar 8;52(3):275-280. doi: 10.2478/raon-2018-0012. Radiol Oncol. 2018. PMID: 30210045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters